Hunter Smith
Fortune : 11 M $ au 31/05/2026
Fortune : 11 M $ au 31/05/2026
Hunter C.
Smith is currently Director at Vanqua Bio, Inc. and Chief Financial Officer & Treasurer at Rhythm Pharmaceuticals, Inc. since 2021.
Former roles include Independent Director at Genesee & Wyoming, Inc. from 2015 to 2019, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Director-Commodities Finance at UBS AG (Stamford Branch) from 1992 to 1999, CFO-Inflammation & Immunology and VP-Finance at Celgene Corp.
from 2013 to 2017, Chief Financial Officer-Sugar & Bioenergy Segment at Bunge Ltd. from 2010 to 2013, and Credit Analyst at Manufacturers Hanover Corp.
from 1990 to 1992.
Education includes undergraduate studies at Northwestern University and an MBA from The Leonard N Stern School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/05/2026 | 119 611 ( 0,17 % ) | 11 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/07/2017 |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/11/2023 |
| GENESEE & WYOMING INC. | Directeur/Membre du Conseil | 30/12/2019 |
| CELGENE | Corporate Officer/Principal | 01/07/2017 |
Bunge Ltd.
Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Public Communications Contact | 01/01/2003 |
UBS AG (Stamford Branch)
UBS AG (Stamford Branch) Financial ConglomeratesFinance Provides financial and investment services | Corporate Officer/Principal | 01/01/1999 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genesee & Wyoming, Inc.
Genesee & Wyoming, Inc. RailroadsTransportation Provides rail freight transportation services | Transportation |
Bunge Ltd.
Bunge Ltd. Agricultural Commodities/MillingProcess Industries Engages in the agriculture and food businesses | Process Industries |
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UBS AG (Stamford Branch)
UBS AG (Stamford Branch) Financial ConglomeratesFinance Provides financial and investment services | Finance |
Manufacturers Hanover Corp.
Manufacturers Hanover Corp. Financial ConglomeratesFinance Operates as a bank holding company | Finance |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national